Anita Kohli, MD

Department

Medicine (Phoenix)

Position

Assistant Professor

Publications

• The Lancet infectious diseases
  Ogbuagu Onyema, Hyland Robert H, Kumar Princy, Luetkemeyer Anne, Lichtman Amos, Mozaffarian Afsaneh, Koullias Yiannis, Goldman Jason D, Gottlieb Robert L, Humeniuk Rita, Llewellyn Joe, Osinusi Anu, Duff Frank, Caro Luzelena, Nadig Priyanka, Kohli Anita, Fusco Dahlene N, Singh Upinder, Shinkai Masaharu, Acloque Gerard, Gonzalez Erika, Chen Shuguang, Davies Santosh, Rodriguez Lauren, Hedskog Charlotte, Etchevers Kim, , Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study 2025
• Journal of hepatology
  Espiritu Christine L., Chuang Wan-Long, Chen Chi-Yi, Gordon Stuart C., Holmes Jacinta, Kohli Anita, Alkhouri Naim, Lam Angela M., Gray Kevin, Sims Karen D., Thi Emily P., Sofia Michael J., Eley Timothy, Anderson Mark, Fortney Tiffany, Cloherty Gavin, Medvedeva Elina, Yuen Man-Fung, Burda Tatiana, Heo Jeong, Nahass Ronald G., Wong Grace Lai-Hung, Bhamidimarri Kalyan, Hu Tsung-Hui, Nguyen Tuan T., Lim Young-Suk, THU-253 IM-PROVE I: Rapid loss followed by transient increases in HBV RNA in chronic hepatitis B subjects during treatment with imdusiran and pegylated interferon alfa-2a is associated with HBsAg seroclearance
  82, p. S832 - S833 2025
• Journal of hepatology
  Alkhouri Naim, Lu Xiaomin, Taub Rebecca, Noureddin Mazen, Charlton Michael R., Moussa Sam, Kohli Anita, Pushkin Richard, Schattenberg Jörn M., LBO-002 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis
  82, p. S9 - S10 2025
• Open forum infectious diseases
  Ogbuagu Onyema, Goldman Jason D, Gottlieb Robert L, Fusco Dahlene, Singh Upinder, Shinkai Masaharu, Acloque Gerard, Gonzalez Erika, Kumar Princy N, Koullias Yiannis, Luetkemeyer Annie, Lichtman Amos, Mozaffarian Afsaneh, Hyland Robert H, Humeniuk Rita, Llewellyn Joe, Osinusi Anu, Duff Frank, Caro Luzelena, Etchevers Kim, Davies Santosh, Hedskog Charlotte, Chen Shuguang, Nadig Priyanka, Kohli Anita, P-2036. Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study
  12:Suppl 1 2025
• Journal of the Pediatric Infectious Diseases Society
  Norton Thomas D, Roque-Guerrero Lilia, Davis John D, Ali Shazia, Hamilton Jennifer D, Thakur Mazhar, Ganguly Samit, Atmodjo Dominique, Hooper Andrea T, Hussein Mohamed, Subramaniam Danise, Chao Jesse, Waldron Alpana, Xiao Jing, Turner Kenneth C, Hughes Diana, Irvin Susan C, Pan Cynthia, Mylonakis Eleftherios, Geba Gregory P, Cox Edward, Kohli Anita, Herman Gary A, Braunstein Ned, Dakin Paula, Kowal Bari, Bhore Rafia, DiCioccio A Thomas, , Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS+IMD) in Pediatric Outpatients With COVID-19 2024
• Journal of hepatology
  Dale Kelly, Alkhouri Naim, Kohli Anita, Nadeem Rida, WED-151 Routine cholestasis genetic testing in patients with intrahepatic cholestasis of pregnancy reveals high prevalence of genetic variants of bile acid transport defects
  80, p. S709 - S710 2024
• Journal of hepatology
  Yuen Man-Fung, Wong Grace Lai-Hung, Heo Jeong, Nahass Ronald G., Burda Tatiana, Bhamidimarri Kalyan Ram, Hu Tsung-Hui, Nguyen Tuan T., Chuang Wan-Long, Chen Chi-Yi, Gordon Stuart C., Holmes Jacinta, Kohli Anita, Alkhouri Naim, Lim Young-Suk, Eley Timothy, Gray Kevin, Thi Emily P., Medvedeva Elina, Ganchua Sharie C., Iott Christina, Eill Elizabeth, Espiritu Christine L., Sims Karen D., Anderson Mark, Fortney Tiffany, Cloherty Gavin, WED-371 Imdusiran (AB-729) administered every 8 weeks in combination with 24 weeks of pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection leads to HBsAg loss in some subjects at end of IFN treatment
  80, p. S809 - S810 2024
• The American journal of gastroenterology
  Leff Phillip, Rida Nadeem, Dinner Brett, Kohli Anita, Naim Alkhouri, Ria Kundu, S3496 A Rare Case of Non-Cirrhotic Portal Hypertension Caused by Necrobiotic Xanthogranuloma
  118:10S, p. S2296 - S2296 2023
• Open forum infectious diseases
  Shapiro Adrienne E, Hussain Rubaba, Acloque Jude, Free Almena, Gonzalez-Rojas Yaneicy, Juarez Erick, Moya Jaynier, Parikh Naval, Yeh Wendy W, Pang Phillip S, Hong David K, Sager Jennifer E, Alexander Elizabeth L, Nader Ahmed, Gaffney Leah A, Kohli Anita, Inman David, Cebrik Deborah, Noormohamed Nadia, Wang Qianwen, Skingsley Andrew, Parra Sergio, Austin Daren, Peppercorn Amanda, Agostini Maria L, Chow Sophia, Mogalian Erik, Sarkis Elias, Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial 2023
• Journal of hepatology
  Yuen Man-Fung, Heo Jeong, Nahass Ronald G, Wong Grace Lai-Hung, Nguyen Tuan, Lim Young-Suk, Chuang Wan-Long, Burda Tatiana, Bhamidimarri Kalyan Ram, Hu Tsung-Hui, Chen Chi-Yi, Gordon Stuart C, Holmes Jacinta, Kohli Anita, Medvedeva Elina, Alkhouri Naim, Gray Kevin, Thi Emily P., Eley Timothy, Sims Karen, LBP-38 - Preliminary safety and antiviral activity of AB-729 combination treatment with pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection
  78, p. S125 - S125 2023
• Journal of hepatology
  Alkhouri Naim, Coste Angie, Topete Jesus, McCallum Meaghan, Blessing Kelly, Noureddin Mazen, Kohli Anita, FRI-525 - The effects of a novel online app (Noom Weight) on weight loss and liver biomarkers in patients with NAFLD: a single arm proof-of-concept study
  78, p. S828 - S828 2023
• Journal of hepatology
  Alkhouri Naim, Kohli Anita, Leff Phillip, Nadeem Rida, Munteanu Mona, SAT-488 - LIVERFASt GP+ (GP+), a non-invasive blood testing for NAFLD staging, improves risk stratification of patients with indeterminate FIB-4 results
  78, p. S711 - S711 2023
• Hepatology communications
  Noureddin Mazen, Vuppalanchi Raj, Mena Edward, Samala Niharika, Wong Micaela, Antaramian Ani, Pacheco Fabiana, Polanco Prido, Sakkal Celine, Chang Devon, Noureddin Nabil, Alkhouri Naim, Kohli Anita, Harrison Stephen A. A., Gwarieh Samer, Truong Emily, Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+and 4 scores
  7:5 2023
• Hepatology (Baltimore, Md.)
  Chang Devon, Yang Ju Dong, Mena Edward A, Pacheco Fabiana, Wong Micaela, Guindi Maha, Todo Tsuyoshi T, Noureddin Nabil, Ayoub Walid, Noureddin Mazen, Harrison Stephen, Truong Emily, Kim Irene K, Kohli Anita, Alkhouri Naim, Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis
  77:2, p. 546 - 557 2023
• Clinical gastroenterology and hepatology
  Lawitz Eric J., Ding Dora, Ruane Peter J., Kohli Anita, Harting Eliza, Chuang Jen-Chieh, Loomba Rohit, Huss Ryan S., Chung Chuhan, Myers Robert P., Bhandari Bal Raj, Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat
  21:1, p. 143 - 152.e3 2023
• Journal of hepatology
  Alkhouri Naim, Herring Robert, Kabler Heidi, Huss Ryan S., Kayali Zeid, Hassanein Tarek, Kohli Anita, Zhu Yanni, Billin Andrew N., Balendran Clare, Damgaard Lars Holm, Buchholtz Kristine, Kjaer Mette Skalshoi, Myers Robert P., Loomba Rohit, Noureddin Mazen, Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
  77:3, p. 607 - 618 2022
• Journal of hepatology
  Noureddin Mazen, Neff Guy, Goodman Zachary, Kohli Anita, Sheikh Aasim, Bhandari Bal Raj, Gunn Nadege, Caldwell Stephen, Huss Ryan, Ma Lily, Ding Dora, Chuang Jay, Poulos John, Chung Chuhan, Myers Robert, Patel Keyur, Borg Brian, Ghalib Reem, Iyer Rajalakshmi, Younes Ziad H., Elkhashab Magdy, Hassanein Tarek, Ruane Peter, Shiffman Mitchell, Strasser Simone, Wong Vincent Wai-Sun, Loomba Rohit, Alkhouri Naim, Kowdley Kris V., The MRI and AST (MAST) score is correlated with noninvasive and histologic markers of fibrosis in patients with advanced fibrosis due to NASH
  77, p. S427 2022
• The lancet. Gastroenterology & hepatology
  Harrison Stephen A., Khazanchi Arun, Sheikh Muhammad Y., Kohli Anita, Leibowitz Mark, Abdelmalek Manal F., Neff Guy, Gunn Nadege, Guy Cynthia D., Alkhouri Naim, Bashir Mustafa R., Freilich Bradley, Bansal Meena, Rinella Mary E., Siddiqui Mohammad S., Kipnes Mark, Moussa Sam E., Younes Ziad H., Baum Seth J., Thuluvath Paul J., Ling Lei, Lieu Hsiao D., Borg Brian, Ruane Peter J., Gottwald Mildred, Chang William, Khan Mujib, Chen Charles, Melchor-Khan Liza, DePaoli Alex M., Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial
  7:7, p. 603 - 616 2022
• Gastroenterology (New York, N.Y. 1943)
  Leff Phillip, Raman Aria, Polanco Prido, Chatha Yash, Garg Pranay, Lantz Kimber A., Gupta Jia, Kahlon Nikhil S., Choudhri Sahil, Kohli Anita, Alkhouri Naim, Tu1311: EXTERNAL VALIDATION OF THE AGILE3+ SCORE AS A PREDICTOR OF ADVANCED FIBROSIS IN A COHORT OF U.S. ADULTS WITH BIOPSYPROVEN NAFLD
  162:7, p. S-1271 2022
• The American journal of gastroenterology
  Harrison Stephen A., Patil Rashmee, Baum Seth J., Gunn Nadege T., Younes Ziad H., Kohli Anita, Koziel Margaret J., Chakravarthy Manu V., Zhao Jeff, Chera Harinder, Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
  116:12, p. 2399 - 2409 2021
• The American journal of gastroenterology
  Prido Polanco, Shrika Kantala, Radha Mantena, Mario D'gyves, Nikhil Kahlon, Pranay Garg, Sahil Choudhri, Vinyas Bhat, Mazen Noureddin, Naim Alkhouri, Yash Chatha, Kohli Anita, Celine Sakkal, S1187 External Validation of an MRI-Based Score to Predict the Presence of Fibrotic NASH
  116:1, p. S551 - S552 2021
• The American journal of gastroenterology
  Polanco Prido, D'gyves Mario, Patil Rashme, Le Phuc, Mantena Radha, Bhat Vinyas, Kantala Shrika, Choudhri Sahil, Garg Pranay, Kahlon Nikhil, Kohli Anita, Chatha Yash, Noureddin Mazen, Harrison Stephen A., Alkhouri Naim, S1186 Evaluation of the FAST Score as a Predictor of Fibrotic NASH in Hispanics
  116:1, p. S551 - S551 2021
• Nature communications
  Harrison Stephen A., Liu Liping, Gunn Nadege, Neff Guy W., Kohli Anita, Flyer Abbey, Goldkind Lawrence, Di Bisceglie Adrian M., A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes
  12:1, p. 5503 - 5503 2021
• American journal of preventive cardiology
  Baum Seth J., Gunn Nadege T., Chakravarthy Manu V., Koziel Margaret J., Harrison Stephen A., Younes Ziad H., Kohli Anita, Zhao Jeff, Patil Rashmee, Fras Juan P., Hamill Michael, Daou Nadine, LIVRQNac (AXA1125) ENHANCES INSULIN SENSITIVITY IN PRIMARY HUMAN HEPATOCYTES AND IN SUBJECTS WITH NAFLD AND T2D
  7, p. 100263 2021
• Hepatology communications
  Younossi Zobair M., Stepanova Maria, Kohli Anita, Noureddin Mazen, Kowdley Kris V., Strasser Simone I., Ruane Peter, Shiffman Mitchell L., Huss Ryan S., Sheikh Aasim, Gunn Nadege, Caldwell Stephen H., Myers Robert P., Wai-Sun Wong Vincent, Loomba Rohit, Alkhouri Naim, Goodman Zachary, Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
  5:7, p. 1201 - 1211 2021
• Diabetes (New York, N.Y.)
  Baum SETH, Zhao JEFF, Frias JUAN P., Hamill MICHAEL, Daou NADINE, Chakravarthy MANU, Koziel MARGARET, Kohli ANITA, Harrison STEPHEN A., Gunn NADEGE T., Younes ZIAD, Patil RASHMEE, 752-P: LIVRQNac (AXA1125) Enhances Insulin Sensitivity in Primary Human Hepatocytes and in Subjects with NAFLD and T2D
  70:Supplement_1 2021
• Hepatology (Baltimore, Md.)
  Loomba Rohit, Gunn Nadege, Sheikh Aasim, Neff Guy, Bhandari Bal Raj, Strasser Simone, Iyer Rajalakshmi, Ruane Peter, Shiffman Mitchell L., Wong Vincent Wai-Sun, Huss Ryan S., Ding Dora, Jia Catherine, Chuang Jen-Chieh, Chung Chuhan, Borg Brian B., Subramanian G. Mani, Myers Robert P., Patel Keyur, Ghalib Reem, Elkhashab Magdy, Kabler Heidi, Poulos John, Younes Ziad, Hassanein Tarek, Resnick Murray, Caldwell Stephen H., Goodman Zachary, Wapinski Ilan, Beck Andrew H., Kohli Anita, Noureddin Mazen, Kowdley Kris V., Alkhouri Naim, , Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
  73:2, p. 625 - 643 2021
• Gastroenterology (New York, N.Y. 1943)
  Harrison Stephen A., Frias Juan P., Younes Ziad, Kohli Anita, Trotter James F., Gunn Nadege T., Moussa Sam E., Nelson Kristin, Bashir Mustafa R., Neff Guy, Guy Cynthia D., Paredes Angelo H., Lieu Hsiao D., Gottwald Mildred, Chang William C.G., Yan Andrew Z., DePaoli Alex M., Ling Lei, Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
  160:1, p. 219 - 231.e1 2021
• Hepatology (Baltimore, Md.)
  Alkhouri Naim, Harrison Stephen A, Kohli Anita, Loomba Rohit, Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic
  72:5, p. 1509 - 1513 2020
• The American journal of gastroenterology
  Aggarwal Pankaj, Alkhouri Naim, Noureddin Mazen, Harrington Allison, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, S1025 The Effects of Age on the Accuracy of the FAST Score to Predict the Presence of NASH With Significant Fibrosis
  115:1, p. S522 - S522 2020
• The American journal of gastroenterology
  Aggarwal Pankaj, Noureddin Mazen, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, Harrington Allison, Alkhouri Naim, S1024 Evaluation of the FAST Score in Patients With Nonalcoholic Fatty Liver Disease and High Liver Stiffness Measurements
  115:1, p. S522 - S522 2020
• The American journal of gastroenterology
  Aggarwal Pankaj, Kohli Anita, Harrington Allison, Singh Tamneet, Cummings-John Oladuni, Noureddin Mazen, Alkhouri Naim, S3286 Identifying Patients With Metabolic Syndrome Who Require Pharmacotherapy for Nonalcoholic Steatohepatitis (NASH) Using the FAST Score
  115:1, p. S1715 - S1715 2020
• The American journal of gastroenterology
  Aggarwal Pankaj, Harrington Allison, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, Noureddin Mazen, Alkhouri Naim, S1190 Identifying Patients With Type 2 Diabetes Mellitus Who Require Pharmacotherapy for Nonalcoholic Steatohepatitis (NASH) Using the FAST Score
  115:1, p. S595 - S595 2020
• Journal of hepatology
  Harrison Stephen A., Younes Ziad H., Patil Rashmee, Koziel Margaret J., Chera Harinder, Zhao Jeff, Chakravarthy Manu V., Baum Seth J., Gunn Nadege T., Kohli Anita, LBP01 - Multifactorial effects of AXA1125 and AXA1957 observed on markers of metabolism, inflammation and fibrosis: a 16-week randomized placebo-controlled study in subjects with non-alcoholic fatty liver disease (NAFLD) with and without type 2 diabetes (
  73, p. S123 - S123 2020
• Journal of hepatology
  Loomba Rohit, Neff Guy, Noureddin Mazen, Kowdley Kris, Kohli Anita, Sheikh Aasim, Bhandari Bal Raj, Gunn Nadege T., Caldwell Stephen, Goodman Zachary, Ding Dora, Wapinski Ilan, Resnick Murray, Beck Andrew, Jia Catherine, Huss Ryan, Chung Chuhan, Subramanian Mani, Ghalib Reem, Myers Robert, Patel Keyur, Borg Brian, Kabler Heidi, Poulos John, Younes Ziad H., Ruane Peter, Elkhashab Magdy, Hassanein Tarek, Iyer Rajalakshmi, Shiffman Mitchell, Strasser Simone, Wong Vincent Wai-Sun, Alkhouri Naim, LBO04 - Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial
  73, p. S116 - S117 2020
• Journal of hepatology
  Harrison Stephen A., Moussa Sam, Younes Ziad H., Trotter James F., Gunn Nadege T., Kohli Anita, Nelson Kristen, Gottwald Mildred, Ling Lei, Chang William, Yan Andrew, Depaoli Alex, Lieu Hsiao, Bashir Mustafa, Neff Guy, Guy Cynthia, Paredes Angelo, Frias Juan, LBO01 - Positive topline results from a 24-week, randomized, double-blind, placebo-controlled, multicenter, phase 2 study of the FGF19 analogue aldafermin (NGM282) in patients with non-alcoholic steatohepatitis
  73, p. S114 - S115 2020
• Liver international
  Pockros Paul J., Hellstern Paul A., Fuchs Michael, Freilich Bradley, Schiff Eugene, Kohli Anita, Lawitz Eric J., Owens-Grillo Janet, Van Biene Courtney, Shringarpure Reshma, MacConell Leigh, Shapiro David, Cohen David E., CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
  39:11, p. 2082 - 2093 2019
• Open forum infectious diseases
  Mera Jorge, Scott John, Joshi Kartik, Thornton Karla, Box Terry, Sedillo Miranda, Manch Richard, Deming Paulina, David Crystal, Essex Whitney, Kohli Anita, Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives
  6:7, p. ofz128 - ofz128 2019
• Hepatology communications
  Shrivastava Shikha, Bhatta Manasa, Rosenthal Elana, Ward Heley, Romani Sara, Lee Rebecca, Osinusi Anu, Kohli Anita, Masur Henry, Kottilil Shyam, Wilson Eleanor, Multitarget Direct-Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus
  2:12, p. 1451 - 1466 2018
• Journal of Viral Hepatitis
  Shrivastava S., Poonia B., Tang L., Osinusi A., Kohli Anita, Wilson E., Kottilil S., Augmentation of Hepatitis C Virus-Specific Immunity and Sustained Virologic Response
  24:9, p. 742 - 749 2017
• Hepatology communications
  Meissner Eric G., Prokunina Olga, Kohli Anita, Higgins Jeanette, Lee Yu‐Jin, Wu David, Orr Cody, Kottilil Shyam, Masur Henry, Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection
  1:7, p. 586 - 594 2017
• Scientific reports
  Nguyen Thi Huyen Tram, Kohli Anita, Guedj Jérémie, Uprichard Susan L, Kottilil Shyam, Perelson Alan S, , The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?
  7:1, p. 10233 - 10233 2017
• Journal of acquired immune deficiency syndromes (1999)
  Wilson Eleanor, Lee Rebecca, Ward Haley, Howard Louisa, Rosenthal Elana, Shrivastava Shikha, Kohli Anita, Masur Henry, Kottilil Shyam, P-C8 Directly acting antiviral therapies have differential effects on cellular and soluble markers of inflammation in success-fully-treated HIV/HCV co-infected patients
  74, p. 80 2017
• Journal of acquired immune deficiency syndromes (1999)
  Rosenthal Elana, Tang Lydia, Hermann Eva, Kohli Anita, Wilson Eleanor, Masur Henry, Bon Dimitra, Kattakuzhy Sarah, Kottilil Shyam, P-C13 Impact of HIV status, HCV genotype, and number of DAAs on HCV viral kinetics in patients with HCV genotype 1 receiving DAA therapy
  74, p. 82 2017
• World journal of hepatology
  Tang Lydia Shuk Yee, Polis Michael, Kottilil Shyam, Osinusi Anu, Kohli Anita, Kattakuzhy Sarah, Nelson Amy, Masur Jack, Sims Zayani, Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
  8:31, p. 1318 - 1326 2016
• Therapeutic advances in gastroenterology
  Kohli Anita, Alshati Ali, Georgie Fawaz, Manch Richard, Gish Robert G., Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease
  9:6, p. 887 - 897 2016
• Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
  Kattakuzhy S., Emmanuel B., Shrivastava S., Tang L., . . . Kottilil, S., Kohli Anita, McLaughlin M., Gross C., Akoth E., McManus M., Wilson E., Sidharthan S., Sims Z., Price A., Silk R., Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease
  62:4, p. 440 - 447 2016
• Clinics in Liver Disease
  Joshi Kartik, Manch Richard, Kohli Anita, Gish Robert, Alcoholic Liver Disease: High Risk Or Low Risk for Developing Hepatocellular Carcinoma?
  20:3, p. 563 - 580 2016
• Journal of Viral Hepatitis
  Meissner E. G., Sturdevant D., Kohli Anita, Virtaneva K., Martens C., Porcella S. F., McHutchison J. G., Masur H., Kottilil S., Achieving Sustained Virologic Response After Interferon-Free Hepatitis C Virus Treatment Correlates with Hepatic Interferon Gene Expression Changes Independent of Cirrhosis
  23:7, p. 496 - 505 2016
• Hepatology international
  Thornton Karla, Manch Richard A, Moore Ann, Sedillo Miranda, Deming Paulina, Scott John, Mera Jorge, Box Terry, Qualls Clifford, Arora Sanjeev, Khaderi Saira, Sussman Norman L, Kohli Anita, Gish Robert, Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment
  10:4, p. 624 - 631 2016
• Gastroenterology (New York, N.Y. 1943)
  Ruane Peter J., Kottilil Shyam, Shiha Gamal, Abergel Armand, Asselah Tarik, Kohli Anita, Naggie Susanna, Doss Wahid, Esmat Gamal, Letterio Cathleen M., Kersey Kathryn, Hahambis Thomas A., Natha Macky, Kreter Bruce, Brainard Diana, Knox Steven, 756 Integrated Analysis of Sof+RBV or LDV/Sof for the Treatment of Genotype 4 Chronic HCV Infection
  150:4, p. S1047 - S1048 2016
• Gastroenterology (New York, N.Y. 1943)
  Flamm Steven, Aqel Bashar, Modi Apurva A., Pungpapong Surakit, Leise Michael D., Natha Macky, Reddy K.R., Curry Michael, Llewellyn Joseph, Williams Laurie, Brainard Diana, Kreter Bruce, Kohli Anita, Wyles David L., Lee Yoori, Su1423 Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/Sof) in Treatment-Experienced Cirrhotic Genotype 1 Patients With Chronic Hepatitis C (CHC): A Comparative Analysis of Gilead Sponsored Trials With 4 Real-World Cohorts (RWC)
  150:4, p. S1095 - S1095 2016
• AIDS Research and Human Retroviruses
  Townsend K., Sampson M., Meissner E. G., Sidharthan S., Remaley A. T., Tang L., Kohli Anita, Osinusi A., Masur H., Kottilil S., Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration
  32:5, p. 456 - 462 2016
• Hepatology International
  Petersen T., Townsend K., Gordon L. A., Sidharthan S., Silk R., Osinusi A., Polis M. A., Masur H., Kottilil S., Kohli Anita, Nelson A., Gross C., Calderon M., Proschan M., High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study
  10:2, p. 310 - 319 2016
• Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
  Wilson E. M., Tang L., Kattakuzhy S., Sidharthan S., Sims Z., McLaughlin M., Price A., Nelson A., Silk R., Subramanian G. M., . . . Kottilil, S., Gross C., Akoth E., Mo H., Kohli Anita, Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens
  62:3, p. 280 - 288 2016
• Clinical Advances in Hematology & Oncology
  Kohli Anita, The Relationship between Hepatocellular Carcinoma and Hepatitis B and C Virus
  14:2, p. 96 - 98 2016
• Expert review of anti-infective therapy
  Nafisi Shirin, Roy Sabyasachi, Gish Robert, Manch Richard, Kohli Anita, Defining the possibilities: is short duration treatment of chronic hepatitis C genotype 1 with sofosbuvir-containing regimens likely to be as effective as current regimens?
  14:1, p. 41 - 56 2016
• Journal of acquired immune deficiency syndromes (1999)
  Kattakuzhy Sarah, Price Angie, Wilson Eleanor, Tang Lydia, Akoth Elizabeth, Nelson Amy, Silk Rachel, Gross Chloe, Kohli Anita, Osinusi Anu, Masur Henry, Kottilil Shyamasundaran, P-B4 Predictors of sustained viral response to 4–6 week duration therapy with Ledipasvir + Sofosbuvir + Gs-9451 +/− Gs-9669 in early and advanced fibrosis (Nih-Ihv synergy trial)
  71:Supplement 1, p. 73 2016
• Journal of acquired immune deficiency syndromes (1999)
  Wilson Eleanor, Osinusi Anu, Mclaughlin Mary, Price Angie, Mo Hongmei, Masur Henry, Kohli Anita, Sims Zayani, Kattakuzhy Sarah, Tang Lydia, P-B11 Retreatment of HCV GT-1 in patients who failed previous short course combination DAA therapy with 12 weeks of LDV/SOF is highly effective
  71:Supplement 1, p. 77 2016
• AIDS (London, England)
  Townsend K., Kohli Anita, Nelson A., Seamon C., Gross C., Tang L., Osinusi A., Polis M. A., Petersen T., Gordon L. A., Masur H., Kottilil S., Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir
  30:2, p. 261 - 266 2016
• Annals of internal medicine
  Kohli Anita, Price Angie, Sims Zayani, Silk Rachel, Gross Chloe, Akoth Elizabeth, Tang Lydia, Jolley Tim A., Emmanuel Benjamin, Proschan Michael, Osinusi Anuoluwapo, Teferi Gebeyehu, Chavez Jose, Abbott Stephen, Mo Hongmei, Polis Michael A., Wilson Eleanor, Masur Henry, Kottilil Shyam, McLaughlin Mary, Seamon Cassie, Meissner Eric G., Sidharthan Sreetha, Nelson Amy, Kattakuzhy Sarah, Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection
  163:12, p. 899 2015
• The American journal of gastroenterology
  Gane Edward, Natha Macky, Asselah Tarik, Kohli Anita, Mir Heshaam M., Kersey Kathryn, Hyland Robert H., Pang Phil, McHutchison John G., Stedman Catherine A. M., Abergel Armand, Ledipasvir/Sofosbuvir With or Without Ribavirin for the Treatment of Patients With Genotype 2-6 Chronic HCV Infection: Summary Results From Four Phase II Studies
  110, p. S870 - S871 2015
• The American journal of gastroenterology
  Gill Kirat, Reynolds Justin, Kohli Anita, Moore Ann, Hepner Ashley, Gish Robert, Manch Richard, A Case of IgG4-Related Disease: A Unique Presentation of a Rare Entity
  110, p. S109 - S110 2015
• The American journal of gastroenterology
  Khosla Manraj, Dunatov Devin, Kohli Anita, Moore Ann, Hepner Ashley, Reynolds Justin, Manch Richard, Gish Robert, Recurrent Post-partum Jaundice: Rare Genetic Disorder With Novel Genetic Mutations Identified
  110, p. S397 2015
• Open forum infectious diseases
  Hahn Katherine J., Kohli Anita, Sims Zayani, Kottilil Shyamasundaran, Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
  2:3, p. ofv091 - ofv091 2015
• Clinical infectious diseases
  Sidharthan Sreetha, Kohli Anita, Kottilil Shyam, Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials Reply
  61:4, p. 667 - 668 2015
• The Lancet infectious diseases
  Kohli Anita, Silk Rachel, Pang Phillip S., Osinusi Anu, Polis Michael A., Rustgi Vinod, Masur Henry, Kottilil Shyam, Kapoor Rama, Sims Zayani, Nelson Amy, Sidharthan Sreetha, Lam Brian, Kotb Colleen, Sugarman Kate, Gross Chloe, Teferi Gebeyehu, Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof of Concept Phase 2a Cohort Study
  15:9, p. 1049 - 1054 2015
• Clinical infectious diseases
  Sidharthan Sreetha, Kohli Anita, Masur Henry, Sims Zayani, Nelson Amy, Osinusi Anu, Kottilil Shyam, Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy
  60:12, p. 1743 - 1751 2015
• Journal of medical virology
  Kohli Anita, Santich Brian, Burbelo Peter, Barrett Lisa, Meissner Eric G., Moir Susan, Shaffer Ashton, Johl Jessica, Sidharthan Sreetha, Fauci Anthony S., Kottilil Shyam, Funk Emily, Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse
  87:4, p. 544 - 552 2015
• JAMA : the journal of the American Medical Association
  Hogan John, Virologic response following combined ledipasvir and sofusbuvir administration in patients with HCV genotype 1 and HIV co-infection
  313:12, p. 1232 2015
• The Lancet (British edition)
  Kohli Anita, Spurlin Emily, Teferi Gebeyehu, Kottilil Shyam, Subramanian G. Mani, Petersen Tess, Townsend Kerry, Egerson D’Andrea, Kapoor Rama, Sneller Michael, Proschan Michael, Herrmann Eva, Kwan Richard, Osinusi Anuoluwapo, Sims Zayani, Nelson Amy, Meissner Eric G., Barrett Lisa L., Bon Dimitra, Marti Miriam M, Silk Rachel, Kotb Colleen, Gross Chloe, Jolley Tim A, Sidharthan Sreetha, Abbott Stephen, Talwani Rohit, Diaz Gabbie, Kleiner David E., Wood Brad J., Chavez Jose, Fauci Anthony S, Masur Henry, McHutchison John, Polis Michael A., Pang Phillip S., Symonds William T., Directly Acting Triple Drug Anti-HCV Therapy Induces Sustained Virologic Response with a Six Week Regimen: A Proof of Concept Phase 2a Cohort Study
  385:9973, p. 1107 - 1113 2015
• JAMA : the journal of the American Medical Association
  Kohli Anita, Kottilil Shyam, Assessment of outcomes of hepatitis C treatment--reply
  312:23, p. 2571 - 2571 2014
• Open forum infectious diseases
  Meissner Eric, Sims Zayani, Kohli Anita, Nelson Amy, Mchutchison John G., Masur Henry, Kottilil Shyam, LB-4Changes in Intrahepatic, Endogenous Interferon Expression in Chronic HCV, Genotype-1 Patients Treated with Interferon-free, Ribavirin-Free DAA Regimens
  1:suppl_1, p. S67 - S67 2014
• Annals of internal medicine
  Osinusi Anu, Pang Phillip S., Subramanian G. Mani, McHutchison John G., Meissner Eric G., Silk Rachel, Kohli Anita, Marti Miriam M., Nelson Amy, Zhang Xiaozhen, Kottilil Shyam, Townsend Kerry, Fauci Anthony S., Masur Henry, Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse An Open-Label Pilot Study
  161:9, p. 634 - U126 2014
• SpringerPlus
  Kohli Anita, Kottilil Shyam, Murphy Allison A, Agarwal Chirdeep, Shivakumar Bhavana, Polis Michael A, Subramanian G Mani, Midha Vandana, Goyal Omesh, Desai Srinivas, Sood Ajit, Shah Samir, HCC surveillance results in earlier HCC detection: results from an Indian cohort
  3:1, p. 1 - 5 2014
• JAMA : the journal of the American Medical Association
  Kohli Anita, Sherman Amy, Kottilil Shyam, Shaffer Ashton, Treatment of Hepatitis C A Systematic Review
  312:6, p. 631 - 640 2014
• AIDS research and human retroviruses
  Shaffer Ashton, Kottilil Shyam, Hubbard Jon J., Townsend Kerry, Polis Michael A., Masur Henry, Kohli Anita, Short Communication: Serum-Based Assay Accurately Detects Single Nucleotide Polymorphisms of IL28B and SOCS3 in HIV/Hepatitis C Virus-Coinfected Subjects
  30:8, p. 792 - 795 2014
• AIDS research and human retroviruses
  Funk Emily K., Shaffer Ashton, Shivakumar Bhavana, Sneller Michael, Kohli Anita, Nelson Amy, Kwan Richard, Kottilil Shyam, Heytens Laura, Polis Michael A., Masur Henry, Short Communication: Interferon/Ribavirin Treatment for HCV Is Associated with the Development of Hypophosphatemia in HIV/Hepatitis C Virus-Coinfected Patients
  29:9, p. 1190 - 1194 2013
• JAMA : the journal of the American Medical Association
  Osinusi Anuoluwapo, Kwan Richard, Teferi Geb, Talwani Rohit, Nelson Amy, Sneller Michael, Meissner Eric G., Heytens Laura, Herrmann Eva, Shivakumar Bhavana, Gu Wenjuan, Lee Yu-Jin, Bon Dimitra, Wroblewski Susan, Kohli Anita, Barrett Lisa, Proschan Michael, Silk Rachel, Kotb Colleen, Fishbein Dawn, Kleiner David, Dewar Robin, Highbarger Helene, Zhang Xiao, Wood Brad J., McHutchison John, Chavez Jose, Symonds William T., Subramanian Mani, Polis Michael A., Fauci Anthony S., Masur Henry, Kottilil Shyamasundaran, Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics A Randomized Clinical Trial
  310:8, p. 804 - 811 2013
• AIDS research and human retroviruses
  Sherman Amy C., Davey Richard T., Trehanpati Nirupama, Daucher Marybeth, Masur Henry, Sarin Shiv Kumar, Kottilil Shyam, Kohli Anita, Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir
  29:4, p. 665 - 672 2013
• Journal of acquired immune deficiency syndromes (1999)
  Sidique Nadeera, Polis Michael A., Masur Henry, Kottilil Shyam, Migueles Stephen, Kohli Anita, Shivakumar Bhavana, Subramanian G. Mani, Naggie Susanna, HIV/HCV-Coinfected Natural Viral Suppressors Have Better Virologic Responses to PEG-IFN and Ribavirin Than ARV-Treated HIV/HCV Patients
  58:2, p. E38 - E40 2011
• The American journal of tropical medicine and hygiene
  Houpt Eric R, Sam Noel E, Bushen Oluma Y, Shao John F, Kohli Anita, Guerrant Richard L, Asgharpour Amon, NG Cherie T, Calfee David P, Maro Venance, OLE-NGUYAINE Sendui, Short report : Asymptomatic Cryptosporidium hominis infection among human immundeficiency virus-infected patients in tanzania
  73:3, p. 520 - 522 2005